Factory-calibrated CGM accurate for diabetics on hemodialysis: Study Medha Baranwal22 July 2022 8:30 PM ISTA factory-calibrated continuous glucose monitor (CGM) appears to be reasonably accurate for individuals on hemodialysis, according to a new...
Efpeglenatide significantly lowers blood sugar and body weight in type 2 diabetes: AMPLITUDE-M trial Medha Baranwal21 July 2022 3:00 PM ISTKorea: Monotherapy with once-weekly efpeglenatide signiifcanly improved blood sugar control and body weight in patients with type 2 diabetes managed...
Overly restrictive salt intake may worsen outcomes for common form of heart failure Isra Zaman20 July 2022 9:30 AM ISTRestricting salt intake is considered a key component of heart failure treatment, but restricting it too much may actually worsen the outcomes for...
Metformin use lowers hepatocellular cancer risk in NAFLD patients with diabetes: Study Medha Baranwal15 July 2022 8:00 PM ISTUSA: The use of metformin may lower the risk of hepatocellular cancer (HCC) in patients with type 2 diabetes and nonalcoholic fatty liver disease...
GLP 1 receptor agonist and insulin combo improves blood sugar, body weight in type 2 diabetes Medha Baranwal14 July 2022 9:00 AM ISTBosnia and Herzegovina: In type 2 diabetes patients treated with premix insulin, switching to IDegLira (a fixed combination of GLP 1 receptor agonist...
Obesity and type 2 diabetes may increase non-vertebral fracture risk in postmenopausal women Medha Baranwal12 July 2022 11:30 AM ISTSpain: Postmenopausal obese women with type 2 diabetes mellitus (T2DM) are at a higher risk of non-vertebral fractures, a recent study published in...
Uptitrating standard dose of teneligliptin fails to improve blood sugar in type 2 diabetes: JAPI Medha Baranwal11 July 2022 12:30 PM ISTMumbai, Maharashtra: Increasing the dose of teneligliptin from 20 to 40 mg at 3 months did not result in statically significant improvement in...
Zydus launches oral solution for type 2 diabetes Roshni Dhar10 July 2022 3:45 PM ISTZydus Lifesciences Ltd., a discovery-driven global lifesciences company has launched the molecule Sitagliptin in India under the brand names Sitaglyn...
Health Bulletin 9/July/2022 Roshni Dhar9 July 2022 5:27 PM ISTHere are the Top Health stories for the day:Medical students taught gender politics with both sexes separated by curtain in classroomControversy...
Zydus Lifesciences unveils anti-diabetic drug molecule Sitagliptin in India Ruchika Sharma9 July 2022 12:00 PM ISTSitagliptin is the gold standard in the Dipeptidyl peptidase 4 inhibitor (DPP4i) category with over 62% market share in the global market.
Probiotic supplementation improves blood sugar control, intestinal health in diabetes patients Medha Baranwal9 July 2022 10:15 AM ISTBrazil: Probiotics use may be an appropriate adjuvant therapy for blood sugar control in type 2 diabetes patients, concludes a recent study in...
Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India Ruchika Sharma7 July 2022 3:28 PM ISTThe medicines will be available under the brand name SITAZIT, SITAZIT- M, SITAZIT- M ER and SITAZIT D.
